

HY-P99032 · 1 mg
MedChemExpress · Cat: HY-P99032
Reach 3+ verified distributors
Manufacturer product page
medchemexpress.com/monalizumab.htmlDescription
Monalizumab IPH2201 is an immune checkpoint inhibitor targeting Natural Killer Group 2A NKG2A . Monalizumab, a humanized anti-NKG2A blocking mAb, increases IFN-? production, thereby promoting NK cell effector functions. Monalizumab can be used for the research of head and neck squamous cell carcinoma HNSCC .